Kilitch Drugs India Ltd — Quarterly Results & Earnings

₹124.45

-9.06%

Profit Growth YoY-4.99%Latest quarter

Sales Growth YoY3.05%Latest quarter

Sales CAGR 5Y30.06%5 year compound

Profit CAGR 5Y158.61%5 year compound

📋

Quarterly Performance

YoY Profit Growth-4.99%

⚠️ Mild contraction

YoY Sales Growth+3.05%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

13.27%

EPS Growth 5Y

156.54%

Interest Coverage

Higher = safer debt servicing

6.85

ROE

12.61%

ROCE

15.67%

💡

Growth Analysis

Kilitch Drugs India Ltd reported YoY profit growth of -4.99% and revenue growth of 3.05% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 30.06% and profits at 158.61% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Kilitch Drugs India Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.